VESIcare Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania
Condition:   Overactive Bladder (OAB) Interventions:   Drug: mirabegron;   Drug: solifenacin;   Drug: darifenacin;   Drug: imidafenacin;   Drug: tolterodine;   Drug: oxybutynin;   Drug: trospium;   Drug: fesoterodine;   Drug: propiverine Sponsor:   Astellas Pharma Singapore Pte. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2018 Category: Research Source Type: clinical trials